{"DataElement":{"publicId":"3005318","version":"1","preferredName":"Late Acute Graft Versus Host Disease Clinical Trial Enrollment Subtype Type","preferredDefinition":"A subtype of the late acute Graft vs Host Disease (GVHD) determined at the time of participant enrollment on a study.","longName":"LT_AC_GVHD_ENRL_SBTP","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"3005297","version":"1","preferredName":"Late Acute Graft Versus Host Disease Clinical Trial Enrollment","preferredDefinition":"Being or occurring at an advanced period of time or after a usual or expected time._A syndrome of immologically mediated tissue damage occurring following allogeneic transplant usually affecting the skin, liver, and gi tract.  Onset is usually within one hundred days of transplantation or immunologic manipulationinformation related to the investigation, analysis and recognition of the presence and nature of graft versus host disease, an incompatibility reaction (which may be fatal) in a subject (host) of low immunological competence (deficient lymphoid tissue) who has been the recipient of immunologically competent lymphoid tissue from a donor who lacks at least one antigen possessed by the recipient host._A research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes. Interventions include but are not restricted to drugs, cells and other biological products, surgical procedures, radiologic procedures, devices, behavioral treatments, process-of-care changes, and preventive care._Enrollment; to insert, register, or enter in a list, catalog, or roll. (Merriam-Webster Online)_.","longName":"LT_ACU_GVHD_ENRL","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"3005294","version":"1","preferredName":"Late Acute Graft Versus Host Disease","preferredDefinition":"Being or occurring at an advanced period of time or after a usual or expected time.:A syndrome of immologically mediated tissue damage occurring following allogeneic transplant usually affecting the skin, liver, and gi tract.  Onset is usually within one hundred days of transplantation or immunologic manipulation.","longName":"C64998:C4980","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Late","conceptCode":"C64998","definition":"Being or occurring at an advanced period of time or after a usual or expected time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Acute Graft Versus Host Disease","conceptCode":"C4980","definition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, usually affecting the skin, liver, and GI tract. The onset is usually within one hundred days of transplantation or immunologic manipulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAAAB23-82CF-3381-E040-BB89AD435A9F","latestVersionIndicator":"Yes","beginDate":"2010-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-02","modifiedBy":"ONEDATA","dateModified":"2010-02-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3005295","version":"1","preferredName":"Clinical Trial Enrollment","preferredDefinition":"A research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes. Interventions include but are not restricted to drugs, cells and other biological products, surgical procedures, radiologic procedures, devices, behavioral treatments, process-of-care changes, and preventive care.:Enrollment; to insert, register, or enter in a list, catalog, or roll. (Merriam-Webster Online)","longName":"C71104:C37948","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Trial","conceptCode":"C71104","definition":"A research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Enrollment","conceptCode":"C37948","definition":"The act of registration, entering in a list, catalog, group, study; also, the number of subjects enrolled.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAAAB23-82E0-3381-E040-BB89AD435A9F","latestVersionIndicator":"Yes","beginDate":"2010-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-02","modifiedBy":"ONEDATA","dateModified":"2010-02-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAAAB23-82F1-3381-E040-BB89AD435A9F","latestVersionIndicator":"Yes","beginDate":"2010-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-02","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3005313","version":"1","preferredName":"Late Acute Graft Versus Host Disease Subtype Type","preferredDefinition":"Being or occurring at an advanced period of time or after a usual or expected time._A syndrome of immologically mediated tissue damage occurring following allogeneic transplant usually affecting the skin, liver, and gi tract.  Onset is usually within one hundred days of transplantation or immunologic manipulation._A group forming a type within a larger type.","longName":"LT_AC_GVHD_SUB_TP","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"15","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Persistent","valueDescription":"Persistent acute GVHD manifestations","ValueMeaning":{"publicId":"3242857","version":"1","preferredName":"Persistent acute GVHD manifestations","longName":"3242857","preferredDefinition":"Persistent acute GVHD manifestations developed from 'classic' (<100 days) that never completely resolved","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A52FC92C-843C-BDEA-E040-BB89AD432CF6","latestVersionIndicator":"Yes","beginDate":"2011-06-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-06-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A52FC92C-8455-BDEA-E040-BB89AD432CF6","beginDate":"2011-06-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-06-08","modifiedBy":"ONEDATA","dateModified":"2011-06-08","deletedIndicator":"No"},{"value":"Late Onset","valueDescription":"Late onset acute GVHD manifestations","ValueMeaning":{"publicId":"3242858","version":"1","preferredName":"Late onset acute GVHD manifestations","longName":"3242858","preferredDefinition":"Late onset acute GVHD manifestations presenting after day 100 in a patient who never had prior acute GVHD","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A52FC92C-845F-BDEA-E040-BB89AD432CF6","latestVersionIndicator":"Yes","beginDate":"2011-06-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-06-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A52FC92C-8478-BDEA-E040-BB89AD432CF6","beginDate":"2011-06-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-06-08","modifiedBy":"ONEDATA","dateModified":"2011-06-08","deletedIndicator":"No"},{"value":"Delayed","valueDescription":"Delayed acute GVHD manifestations","ValueMeaning":{"publicId":"3242859","version":"1","preferredName":"Delayed acute GVHD manifestations","longName":"3242859","preferredDefinition":"Delayed acute GVHD manifestations presenting for the first time after Day 100 of transplantation or Donor Lymphocyte Infusion (DLI)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A52FC92C-8482-BDEA-E040-BB89AD432CF6","latestVersionIndicator":"Yes","beginDate":"2011-06-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-06-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A52FC92C-849B-BDEA-E040-BB89AD432CF6","beginDate":"2010-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-06-08","modifiedBy":"ONEDATA","dateModified":"2011-06-08","deletedIndicator":"No"},{"value":"Prolonged","valueDescription":"Prolonged acute GVHD manifestations","ValueMeaning":{"publicId":"3242860","version":"1","preferredName":"Prolonged acute GVHD manifestations","longName":"3242860","preferredDefinition":"Prolonged acute GVHD manifestations that started before Day 100 and continue beyond Day 100","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A52FC92C-84A5-BDEA-E040-BB89AD432CF6","latestVersionIndicator":"Yes","beginDate":"2011-06-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-06-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A52FC92C-84BE-BDEA-E040-BB89AD432CF6","beginDate":"2010-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-06-08","modifiedBy":"ONEDATA","dateModified":"2011-06-08","deletedIndicator":"No"},{"value":"Recurrent","valueDescription":"Recurrent acute GVHD manifestations","ValueMeaning":{"publicId":"3242861","version":"1","preferredName":"Recurrent acute GVHD manifestations","longName":"3242861","preferredDefinition":"Recurrent acute GVHD manifestations after Day 100 that reappear in a patient who had prior classic (<100 days) acute GVHD","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A52FC92C-84C8-BDEA-E040-BB89AD432CF6","latestVersionIndicator":"Yes","beginDate":"2011-06-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-06-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A52FC92C-84E1-BDEA-E040-BB89AD432CF6","beginDate":"2010-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-06-08","modifiedBy":"ONEDATA","dateModified":"2011-06-08","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3005312","version":"1","preferredName":"Late Acute Graft Versus Host Disease Subtype Type","preferredDefinition":"Being or occurring at an advanced period of time or after a usual or expected time.:A syndrome of immologically mediated tissue damage occurring following allogeneic transplant usually affecting the skin, liver, and gi tract.  Onset is usually within one hundred days of transplantation or immunologic manipulation.:Subtype; a group forming a type within a larger type.:Type; a subdivision of a particular kind of thing.","longName":"C64998:C4980:C25696:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Late","conceptCode":"C64998","definition":"Being or occurring at an advanced period of time or after a usual or expected time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Acute Graft Versus Host Disease","conceptCode":"C4980","definition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, usually affecting the skin, liver, and GI tract. The onset is usually within one hundred days of transplantation or immunologic manipulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Subtype","conceptCode":"C25696","definition":"A group forming a type within a larger type.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAB8C7C-CD67-328C-E040-BB89AD433B37","latestVersionIndicator":"Yes","beginDate":"2010-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-02","modifiedBy":"ONEDATA","dateModified":"2010-02-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAB8C7C-CD78-328C-E040-BB89AD433B37","latestVersionIndicator":"Yes","beginDate":"2010-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-02","modifiedBy":"REEVESD","dateModified":"2011-06-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Late Acute GVHD subtype","type":"Preferred Question Text","description":"Late Acute GVHD subtype","url":null,"context":"CCR"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAB8C7C-CDF4-328C-E040-BB89AD433B37","latestVersionIndicator":"Yes","beginDate":"2010-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-02","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeDescription":"Curated to support CCR Transplantation trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}